Obesity, aerobic exercise, and vascular disease: the role of oxidant stress (Q34844350)

4 August 2017

1 reference

title

Obesity, aerobic exercise, and vascular disease: the role of oxidant stress (English)

1 reference

4 August 2017

0 references

1 reference

3

Victor M Darley-Usmar

1 reference

4 August 2017

1

Catherine P Fenster

1 reference

4 August 2017

2

Roland L Weinsier

1 reference

4 August 2017

Rakesh P Patel

4

1 reference

4 August 2017

publication date

1 September 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

10

1 reference

4 August 2017

issue

9

1 reference

4 August 2017

page(s)

964-968

1 reference

Annual Deaths Attributable to Obesity in the United States

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Biological aspects of reactive nitrogen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Oxidants as stimulators of signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Exercise training in coronary artery disease and coronary vasomotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Strenuous endurance training in humans reduces oxidative stress following exhausting exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Induction of glutathione synthesis by oxidized low-density lipoprotein and 1-palmitoyl-2-arachidonyl phosphatidylcholine: protection against quinone-mediated oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Oxidative stress in a rat model of obesity-induced hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Cell signaling by reactive nitrogen and oxygen species in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

The in vitro oxidizability of lipoprotein particles in obese and non-obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Cytosolic triglycerides and oxidative stress in central obesity: the missing link between excessive atherosclerosis, endothelial dysfunction, and beta-cell failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Myeloperoxidase-generated oxidants and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

The role of oxidized lipoproteins in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Role of arterial wall antioxidant defense in beneficial effects of exercise on atherosclerosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Mechanisms underlying endothelial dysfunction in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Effects of glucose/insulin perturbations on aging and chronic disorders of aging: the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Did the antioxidant trials fail to validate the oxidation hypothesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Exercise training increases basal nitric oxide production from the forearm in hypercholesterolemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Nitric oxide and the regulation of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Exercise training-induced alterations in skeletal muscle antioxidant capacity: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Exercise in weight management of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

A Prospective Study of Walking as Compared with Vigorous Exercise in the Prevention of Coronary Heart Disease in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

The induction of GSH synthesis by nanomolar concentrations of NO in endothelial cells: a role for γ-glutamylcysteine synthetase and γ-glutamyl transpeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Nitric oxide homeostasis control as therapy for cardiovascular diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Cellular regulation of endothelial nitric oxide synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Obesity is associated with increased myocardial oxidative stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Effect of a diet supplemented with thioproline on murine macrophage function in a model of premature ageing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Glucose scavenging of nitric oxide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

Exercise intensity and risk of chronic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.131

31 March 2020

Identifiers

DOI

10.1038/OBY.2002.131

1 reference

4 August 2017

1 reference